This inventor holds 1 USPTO granted patent. Top assignee: Sungkyunkwan University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Brain Disease Treatment by Jae Hoon Sul
Introduction
Jae Hoon Sul is an innovative inventor based in Anyang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of brain diseases. His work focuses on utilizing stem cell-derived exosomes to develop effective therapeutic compositions.
Latest Patents
Jae Hoon Sul holds a patent for a pharmaceutical composition aimed at preventing or treating brain diseases. This composition comprises a stem cell-derived exosome that is surface-modified with a compound capable of binding to dopamine receptors or L-amino acid transporters. The patent highlights the selective binding of the exosome to dopamine receptors (D2) overexpressed in dopaminergic neurons, particularly in the substantia nigra. This innovative approach allows for local accumulation in dopaminergic neurons, which is crucial for effective treatment. The stem cell-derived exosome has demonstrated excellent neuron protective effects and the ability to inhibit neuron death. This composition is expected to be beneficial in treating brain diseases, including Parkinson's disease and Alzheimer's disease.
Career Highlights
Jae Hoon Sul is affiliated with Sungkyunkwan University, where he continues to advance his research in the field of neuroscience and pharmaceuticals. His work has garnered attention for its potential impact on treating debilitating brain conditions.
Collaborations
Jae Hoon Sul collaborates with notable colleagues, including Jae Hyung Park and Dong Gyu Jo. Their combined expertise contributes to the innovative research and development of new therapeutic strategies.
Conclusion
Jae Hoon Sul's contributions to the field of brain disease treatment through his innovative patent highlight the potential of stem cell-derived exosomes in pharmaceuticals. His work represents a significant advancement in the search for effective therapies for conditions like Parkinson's and Alzheimer's diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
